Crystal structure of the Alcanivorax borkumensis YdaH transporter reveals an unusual topology

Nature Communications

Volumn 6, Issue , 2015, Pages

  Bolla, Jani Reddy ^a   Su, Chih Chia ^a   Delmar, Jared A ^a   Radhakrishnan, Abhijith ^a   Kumar, Nitin ^a   Chou, Tsung Han ^a   Long, Feng ^a   Rajashankar, Kanagalaghatta R ^b   Yu, Edward W ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b Department of Physics and Astronomy Iowa State University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBENZOIC ACID; 4 AMINOBENZOYL GLUTAMATE; ANTIBIOTIC AGENT; ANTIMETABOLITE; FOLIC ACID; GLUTAMIC ACID DERIVATIVE; MEMBRANE PROTEIN; SULFADIAZINE; SULFADIMIDINE; SULFANILAMIDE; SULFATHIAZOLE; SULFONAMIDE; TRITIUM; UNCLASSIFIED DRUG; YDAH TRANSPORTER; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CARRIER PROTEIN;

ANTIBIOTICS; BACTERIUM; CRYSTAL STRUCTURE; CYTOPLASM; DISEASE RESISTANCE; MICROBIAL ACTIVITY; PATHOGEN;

ALCANIVORAX; ALCANIVORAX BORKUMENSIS; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLIZATION; DRUG TARGETING; GENE; METABOLITE; MOLECULE; MUTANT; NONHUMAN; PROTEIN STRUCTURE; SITE DIRECTED MUTAGENESIS; YDAH GENE; ALCANIVORAXACEAE; DRUG EFFECTS; ESCHERICHIA COLI; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR MODEL; PHYSIOLOGY; PROTEIN CONFORMATION;

ALCANIVORAX BORKUMENSIS; BACTERIA (MICROORGANISMS);

ALCANIVORACEAE; ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; CARRIER PROTEINS; ESCHERICHIA COLI; FOLIC ACID; GENE DELETION; GENE EXPRESSION REGULATION, BACTERIAL; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; PROTEIN CONFORMATION; SULFAMETHAZINE;

EID: 84928139359     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7874     Document Type: Article

References (47)

1. Henderson, G. B. & Huennekens, F. M. Membrane-Associated folate transport proteins. Methods Enzymol. 122, 260-269 (1986).
2. Hyde, J. E. et al. Plasmodium falciparum: a paradigm for alternative folate biosynthesis in diverse microorganisms? Trends Parasitol. 24, 502-508 (2008).
3. Pyne, C. & Bognar, A. L. Replacement of the folC gene, encoding folylpolyglutamate synthetase-dihydrofolate synthetase in Escherichia coli, with genes mutagenized in vitro. J. Bacteriol. 174, 1750-1759 (1992).
4. Woods, D. D. The relationship of p-Aminobenzoic acid to the mechanism of the action of sulphanilamide. Br. J. Exp. Pathol. 21, 74-90 (1940).
5. Bermingham, A. & Derrick, J. P. The folic acid biosynthesis pathway in bacteria: evaluation of potential for antibacterial drug discovery. Bioassays 24, 637-648 (2002).
6. Singer, M., Nambiar, S., Valappil, T., Higgins, K. & Gitterman, S. Historical and regulatory perspectives on the treatment effect of antibacterial drugs for community-Acquired pneumonia. Clin. Infect. Dis. 47, S216-S224 (2008).
7. Cartwright, K. A. V. (ed.) Meningococcal Disease (John Wiley & Sons, 1995).
8. Wang, P., Read, M., Sims, P. F. G. & Hyde, J. E. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization. Mol. Microbiol. 23, 979-986 (1997).
9. Triglia, T. & Cowman, A. F. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc. Natl Acad. Sci. USA 91, 7149-7153 (1994).
10. Triglia, T., Menting, J. G., Wilson, C. & Cowman, A. F. Mutations in dihydropteroate synthase are responsible for sulfon and sulfonamide resistance in Plasmodium falciparum. Proc. Natl Acad. Sci. USA 94, 13944-13949 (1997).
11. Brown, G. M., Weisman, R. A. & Molnar, D. A. The biosynthesis of folic acid: I. Substrate and cofactor requirements for enzymatic synthesis by cell-free extracts of Escherichia coli. J. Biol. Chem. 236, 2534-2543 (1961).
12. Brown, G. M. The biosynthesis of folic acid: II. Inhibition by sulfonamides. J. Biol. Chem. 237, 536-540 (1962).
13. Reynolds, J. J. & Brown, G. M. The biosynthesis of folic acid. IV. Enzymatic synthesis of dihydrofolic acid from guanine and ribose compounds. J. Biol. Chem. 239, 317-325 (1964).
14. Burg, A. W. & Brown, G. M. The biosynthesis of folic acid VI. Enzymatic conversion of carbon atom 8 of guanosine triphosphate to formic acid. Biochim. Biophys. Acta 117, 275-278 (1966).
15. Richey, D. P. & Brown, G. M. The biosynthesis of folic acid. IX. Purification and properties of the enzymes required for the formation of dihydropteroic acid. J. Biol. Chem. 244, 1582-1592 (1969).
16. Mathis, J. B. & Brown, G. M. The biosynthesis of folic acid. XI. Purification and properties of dihydroneopterin aldolase. J. Biol. Chem. 245, 3015-3025 (1970).
17. Hussein, M. J., Green, J. M. & Nichols, B. P. Characterization of mutations that allow p-Aminobenzoyl-glutamate utilization by Escherichia coli. J. Bacteriol. 180, 6260-6268 (1998).
18. Carter, E. L. et al. Escherichia coli abg genes enable uptake and cleavage of the folate catabolite p-Aminobenzoyl-glutamate. J. Bacteriol. 189, 3329-3334 (2007).
19. Prakash, S., Cooper, G., Singhi, S. & Saier, Jr. M. H. The ion transporter superfamily. Biochim. Biophys. Acta 1618, 79-92 (2003).
20. Veal, W. L. & Shafer, W. M. Identification of a cell envelope protein (MtrF) involved in hydrophobic antimicrobial resistance in Neisseria gonorrhoeae. J. Antimicrob. Chemother. 51, 27-37 (2003).
21. Folster, J. P. & Shafer, W. M. Regulation of mtrF expression in Neisseria gonorrhoeae and its role in high-level antimicrobial resistance. J. Bacteriol. 187, 3713-3720 (2005).
22. Schneiker, S. et al. Genome sequence of the ubiquitous hydrocarbon degrading marine bacterium Alcanivorax borkumensis. Nat. Biotechnol. 24, 997-1004 (2006).
23. Daley, D. O. et al. Global topology analysis of the Escherichia coli inner membrane proteome. Science 308, 1321-1323 (2005).
24. Nayal, M. & Di Cera, E. Valence screening of water in protein crystals reveals potential Na+ binding sites. J. Mol. Biol. 256, 228-234 (1996).
25. Kaplan, J. B. & Nichols, B. P. Nucleotide sequence of Escherichia coli pabA and its evolutionary relationship to trp(G)D. J. Mol. Biol. 168, 451-468 (1986).
26. Wilson, S. D. & Horne, W. D. Use of glycerol-crypotected Lactobacillus casei for microbiological assay of folic acid. Clin. Chem. 28, 1198-1200 (1982).
27. Unemo, M. & Shafer, W. M. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin. Microbiol. Rev. 27, 587-613 (2014).
28. Tseng, T. T. et al. The RND permease superfamily: an ancient, ubiquitous and diverse family that includes human disease and development protein. J. Mol. Microbiol. Biotechnol. 1, 107-125 (1999).
29. Brown, M. H., Paulsen, I. T. & Skurray, R. A. The multidrug efflux protein NorM is a prototype of a new family of transporters. Mol. Microbiol. 31, 394-395 (1999).
30. Ethayathulla, A. S. et al. Structure-based mechanism for Na+/melibiose symport by MelB. Nat. Commun. 5, 3009 (2014).
31. Long, F. et al. Crystal structures of the CusA heavy-metal efflux pump suggest methionine-mediated metal transport mechanism. Nature 467, 484-488 (2010).
32. Otwinowski, Z. & Minor, M. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326 (1997).
33. Tézé, A. & Hervé, G. a-, b-, and g-dodecatungstosilicic acids: isomers and related lacunary compounds. Inorg. Synth. 27, 85-96 (1990).
34. Schneider, T. R. & Sheldrick, G. M. Substructure solution with SHELXD. Acta Crystallogr. D Biol. Crystallogr. D58, 1772-1779 (2002).
35. Pape, T. & Schneider, T. R. HKL2MAP: a graphical user interface for macromolecular phasing with SHELX programs. J. Appl. Crystallogr. 37, 843-844 (2004).
36. Otwinowski, Z. MLPHARE, CCP4 Proc. 80 (Daresbury Laboratory, 1991).
37. Collaborative Computational Project No. 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. D50, 760-763 (1994).
38. Terwilliger, T. C. Maximum-likelihood density modification using pattern recognition of structural motifs. Acta Crystallogr. D Biol. Crystallogr. D57, 1755-1762 (2001).
39. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. D60, 2126 (2004).
40. McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658-674 (2007).
41. Adams, P. D. et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D Biol. Crystallogr. 58, 1948-1954 (2002).
42. Brünger, A. T. et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. D54, 905-921 (1998).
43. Lu, M. et al. Structures of a Na+-coupled, substrate-bound MATE multidrug transporter. Proc. Natl Acad. Sci. USA 110, 2099-2104 (2013).
44. Long, F., Rouquette-Loughlin, C., Shafer, W. M. & Yu, E. W. Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli. Antimicrob. Agents Chemother. 52, 3052-3060 (2008).
45. Kulathila, R., Kulathila, R., Indic, M. & van den Berg, B. Crystal structure of Escherichia coli CusC, the outer membrane component of a heavy metal efflux pump. PLoS ONE 6, 15610 (2011).
46. Lei, H. T., Bolla, J. R., Bishop, N. R., Su, C. C. & Yu, E. W. Crystal structures of CusC review conformational changes accompanying folding and transmembrane channel formation. J. Mol. Biol. 426, 403-411 (2014).
47. Datsenko, K. A. & Wanner, B. L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl Acad. Sci. USA 97, 6640-6645 (2000).